Andrew Nunn, Professor of Epidemiology in the Medical Research Council Clinical Trials Unit at UCL, analyses different tuberculosis drug development regimens
This piece has moved to our Academic Articles Section, find the full text here: ‘Tuberculosis drug regimens and their efficacies‘
